Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 47

JAMA Network

This 3-year follow-up of a randomized clinical trial assesses the long-term safety and efficacy of P2Y12 inhibitor monotherapy following 3 months of dual antiplatelet